Emes2 Pharmaceuticals, LLC
Clearwater, FL Doing business as RX Return Services
- UEI
- L9BAWRKDMLD4
- CAGE
- 7UN82
- Primary NAICS
- 456110 Pharmacies and Drug Retailers
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1115 Old Coachman Rd., Clearwater, FL 33765, USA
- Website
- rxrs.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 51 Wholesale Trade – Nondurable Goods
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $120,160 |
| FY2025 | $92,545 |
| FY2024 | $83,100 |
| FY2023 | $42,500 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $109,000 | |
| 2 | Department of Justice | $11,160 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Pharmalink Inc. | Largo, FL | 541614 Process, Physical Distribution, and Logistics Consulting Services |
| Outdate RX LLC | Redlands, CA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| United RX Solutions | Bohemia, NY | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Pharma Logistics | Libertyville, IL | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Logmet Solutions | Decatur, GA | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
About the company
Emes2 Pharmaceuticals, LLC, doing business as RX Return Services, is a self-certified small disadvantaged business headquartered in Clearwater, Florida, that provides pharmaceutical reverse distribution, controlled substance destruction, and pharmacy waste management services to federal healthcare and correctional agencies exclusively as a prime contractor. The company operates as a limited liability partnership structured for profit, competing on total small business set-asides and full-and-open procurements with no subcontractor footprint.
The vendor's capability portfolio centers on on-site pharmaceutical inventory review, expired medication removal and destruction, DEA-controlled substance management, manufacturer credit recovery, and electronic tracking and compliance reporting at federal pharmacy facilities. Recent representative work includes a $172.5 thousand total small business set-aside purchase order from the Indian Health Service (awarded September 2026) covering reverse distribution services across three Albuquerque Area IHS facilities through September 2031 with quarterly on-site specialist visits; a $156.6 thousand total small business award from IHS's Santa Fe Indian Health Center (awarded June 2022, extending through June 2027) for pharmacy reverse distributor services; and a $60.17 thousand delivery order from the Department of Veterans Affairs Veterans Integrated Service Network 16 (awarded January 2024) for expired pharmaceutical removal and destruction at the Overton Brooks VA Medical Center in Louisiana.
Customer concentration is heavily weighted toward the Indian Health Service, which accounts for 9 awards and $522 thousand of combined potential value (69% of the portfolio) across service units in New Mexico and Arizona. The Department of Veterans Affairs Veterans Integrated Service Network 16 places the second-largest concentration at 5 awards and $192 thousand, anchored by a $55.28 thousand single-award Indefinite Delivery Contract running through January 2029 for reverse distribution at VA facilities in Louisiana. The Department of Justice Bureau of Prisons Federal Correctional Institutions collectively represent 7 awards and $37 thousand across Terminal Island, Marion, Fort Worth, and Otisville facilities. These three customer tiers account for 95% of recent awards. Award activity shows volatility (five awards in 2022, two in 2023, six in 2024, two in 2025, five in 2026) with a combined potential value of $756 thousand and $446 thousand in obligated dollars (59% obligation rate). Four awards totaling $293 thousand in potential value face ultimate completion dates within the next twenty-four months, representing meaningful recompete exposure. The vendor holds position on one named parent IDV—the VA's Indefinite Delivery Contract 36C25624D0030—which carries two task orders valued at $71 thousand. Categorically, work splits across pharmacies and drug retailers (six awards), pharmaceutical preparation manufacturing (four awards), and hazardous waste collection (four awards), with primary PSC codes in drugs and biologicals and pharmacy services.
Quick answers
Is Emes2 Pharmaceuticals, LLC registered in SAM.gov?
Yes. Emes2 Pharmaceuticals, LLC's SAM.gov registration is active through September 17, 2027.
How much has Emes2 Pharmaceuticals, LLC received in federal contracts?
Federal contracts obligated $92,545 to Emes2 Pharmaceuticals, LLC in fiscal year 2025 and $338,305 in fiscal years 2023 through 2027.
How does Emes2 Pharmaceuticals, LLC rank among federal contractors?
Emes2 Pharmaceuticals, LLC ranked #16 in NAICS 456 and #16 in PSC P1 in FY2025.
What is Emes2 Pharmaceuticals, LLC's most recent federal award?
Emes2 Pharmaceuticals, LLC's most recent federal contract award is Reverse distribution services for expired pharmaceuticals, albuquerque service unit (7571PS26P00038), from Assistant Secretary for Financial Resources, on September 15, 2026.
On GovTribe
See Emes2 Pharmaceuticals, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors